Back to TCDA Stock Lookup

(TCDA) – Business Wire

Jan 27, 2021 09:00 AM Notice of Lead Plaintiff Deadline for Shareholders in the Tricida, Inc. Class Action Lawsuit
Oct 29, 2020 07:30 AM Tricida Provides Update on FDA Interactions
Oct 28, 2020 04:00 PM Tricida to Provide Update from its End-of-Review Type A Meeting with the FDA
Oct 9, 2020 11:00 AM Tricida Announces Twelve Data Presentations on Veverimer and Metabolic Acidosis to be Given at the Virtual American Society of Nephrology Kidney Week 2020
Aug 24, 2020 08:30 AM Tricida Receives Complete Response Letter from the FDA for its New Drug Application for Veverimer for the Treatment of Metabolic Acidosis and Slowing of Kidney Disease Progression in Patients with Met
Aug 5, 2020 04:05 PM Tricida Announces Second Quarter 2020 Financial Results
Jul 29, 2020 01:00 PM Tricida to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on Wednesday, August 5, 2020
Jul 15, 2020 05:00 PM Tricida Provides Regulatory Update on Veverimer
Jun 3, 2020 04:39 PM Tricida Announces that 2020 Annual Meeting Will be Held in Virtual Format
Jun 2, 2020 10:00 AM Tricida to Present at the Goldman Sachs Virtual Healthcare Conference
May 22, 2020 04:05 PM Tricida Announces Closing of Offering of $200 Million of 3.50% Convertible Senior Notes Due 2027, Including Full Exercise of Option to Purchase Additional Notes
May 20, 2020 12:32 AM Tricida Prices Offering of $175 Million 3.50% Convertible Senior Notes Due 2027
May 19, 2020 08:13 AM Tricida Announces Proposed Offering of $175 Million Convertible Senior Notes Due 2027
May 7, 2020 04:05 PM Tricida Announces First Quarter 2020 Financial Results
Apr 30, 2020 10:00 AM Tricida to Report First Quarter 2020 Financial Results and Host Conference Call and Webcast on Thursday, May 7, 2020
Apr 9, 2020 11:43 AM Tricida to Present at the Needham Virtual Healthcare Conference
Mar 24, 2020 08:30 AM Tricida Announces Multiple Data Presentations on Veverimer and Metabolic Acidosis to Be Given at the Virtual National Kidney Foundation 2020 Spring Clinical Meetings
Mar 12, 2020 09:00 AM Tricida Supports the National Kidney Foundation in Asking “Are You the 33%?”
Mar 9, 2020 08:30 AM Tricida Hires Robert McKague as Executive Vice President, General Counsel & Chief Compliance Officer
Feb 27, 2020 04:05 PM Tricida Announces Fourth Quarter and Full-Year 2019 Financial Results
Feb 24, 2020 04:15 PM Tricida to Present at the Cowen 40th Annual Health Care Conference
Feb 19, 2020 10:00 AM Tricida to Report Fourth Quarter and Year End 2019 Financial Results and Host Conference Call and Webcast on Thursday, February 27, 2020
Jan 7, 2020 01:59 PM Tricida to Present at the 38th Annual J. P. Morgan Healthcare Conference
Dec 3, 2019 08:00 AM Tricida Announces Hiring of Elizabeth Faust, Ph.D., as Senior Vice President of Medical Affairs
Nov 25, 2019 10:00 AM Tricida to Present at the Evercore Annual Global Healthcare Conference
Nov 14, 2019 04:08 PM Tricida Announces Third Quarter 2019 Financial Results
Nov 14, 2019 04:03 PM Tricida Announces FDA Acceptance of New Drug Application for Veverimer
Nov 5, 2019 10:00 AM Tricida to Report Third Quarter Financial Results and Host Conference Call and Webcast on Thursday, November 14, 2019
Oct 4, 2019 10:24 AM Tricida to Host Investor Day on October 15, 2019
Oct 2, 2019 08:30 AM Tricida Announces Multiple Data Presentations on Metabolic Acidosis to be Given at ASN Kidney Week 2019
Sep 12, 2019 08:56 AM Tricida Launches Metabolic Acidosis Insights, an Online Educational Resource for the Healthcare Community
Sep 4, 2019 08:30 AM Tricida Announces Submission of New Drug Application for Veverimer for the Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease
Aug 8, 2019 04:05 PM Tricida Announces Second Quarter 2019 Financial Results
Aug 1, 2019 10:00 AM Tricida to Report Second Quarter Financial Results and Host Conference Call and Webcast on Thursday, August 8, 2019

Back to TCDA Stock Lookup